Yeom Kyeong-Min, Chang Jong-In, Yoo Jeong-Ju, Moon Ji Eun, Sinn Dong Hyun, Kim Young Seok, Kim Sang Gyune
Department of Internal Medicine, SoonChunHyang University School of Medicine, Bucheon 14584, Republic of Korea.
Department of Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong 06973, Republic of Korea.
Diagnostics (Basel). 2023 Dec 25;14(1):39. doi: 10.3390/diagnostics14010039.
It is well known that renal dysfunction has a devastating effect on the prognosis of liver cirrhosis. In this study, the aim was to assess whether the incorporation of the kidney dysfunction type into the MELD-Na score enhances its predictive capacity for outcomes in patients awaiting liver transplantation (LT), compared to utilizing the MELD 3.0 score with albumin. In total, 2080 patients awaiting the LT were enrolled at two tertiary care institutions in Korea. Discrimination abilities were analyzed by using Harrell's c-index and iAUC values between MELD-Na-kidney dysfunction type (MELD-Na-KT) and MELD 3.0 with albumin. Clinical endpoints encompassed 3-month survival, 3-month transplant-free survival (TFS), overall survival (OS), and total TFS. Out of the total of 2080 individuals, 669 (32.16%) were male. Regarding the types of renal function impairment, 1614 (77.6%) were in the normal group, 112 (5.38%) in the AKD group, 320 (15.35%) in the CKD group, and 34 (1.63%) were in the AKD on CKD group. MELD 3.0 with albumin showed better discrimination (c-index = 0.714) compared to MELD-Na-KT (c-index = 0.708) in predicting 3-month survival. Similar results were observed for OS, 3-month TFS, and total TFS as well. When divided by sex, MELD 3.0 with albumin showed the comparable prediction of 3-month survival to MELD-Na-KT (c-index 0.675 vs. 0.671, -value 0.221) in males. However, in the female group, MELD 3.0 with albumin demonstrated better results compared to MELD-Na-KT (c-index 0.733 vs. 0.723, -value 0.001). The integration of kidney dysfunction types into the MELD-Na did not yield superior prognostic results compared to the MELD 3.0 score with albumin. Rather, in the female group, the MELD 3.0 score with albumin was better able to predict survival. These findings suggest that laboratory values pertaining to liver dysfunction or creatinine levels may be more significant than the type of kidney dysfunction when predicting the short-term prognosis of LT candidates.
众所周知,肾功能不全对肝硬化的预后具有毁灭性影响。在本研究中,目的是评估将肾功能不全类型纳入MELD-Na评分与使用含白蛋白的MELD 3.0评分相比,是否能增强其对等待肝移植(LT)患者预后的预测能力。韩国两家三级医疗机构共纳入了2080例等待LT的患者。通过使用Harrell的c指数和iAUC值分析了MELD-Na-肾功能不全类型(MELD-Na-KT)与含白蛋白的MELD 3.0之间的区分能力。临床终点包括3个月生存率、3个月无移植生存率(TFS)、总生存率(OS)和总TFS。在总共2080名个体中,669名(32.16%)为男性。关于肾功能损害类型,1614名(77.6%)在正常组,112名(5.38%)在急性肾损伤(AKD)组,320名(15.35%)在慢性肾脏病(CKD)组,34名(1.63%)在CKD基础上的AKD组。在预测3个月生存率方面,含白蛋白的MELD 3.0比MELD-Na-KT表现出更好的区分能力(c指数 = 0.714对0.708)。OS、3个月TFS和总TFS也观察到了类似结果。按性别划分时,含白蛋白的MELD 3.0在男性中对3个月生存率的预测与MELD-Na-KT相当(c指数0.675对0.671,P值0.221)。然而,在女性组中,含白蛋白的MELD 3.0比MELD-Na-KT表现出更好的结果(c指数0.733对0.723,P值0.001)。与含白蛋白的MELD 3.0评分相比,将肾功能不全类型纳入MELD-Na并未产生更好的预后结果。相反,在女性组中,含白蛋白的MELD 3.0评分更能预测生存率。这些发现表明,在预测LT候选者的短期预后时,与肝功能不全或肌酐水平相关的实验室值可能比肾功能不全类型更重要。